Clinical Trials - Phase III
Filter News
Found 21,779 articles
-
Onyx Pharmaceuticals, Inc. And Bayer Corporation Drug Gets Fast Track For Liver Cancer
6/13/2006
-
Novartis Corporation Unveils Further Impressive Efficacy Data For Galvus(R), An Investigational Oral Diabetes Compound, Showing Significant Blood Sugar Reductions
6/13/2006
-
Merck & Co., Inc. Release: In New Data at One Year, JANUVIA(TM), An Investigational Medicine For Type 2 Diabetes, Demonstrated Substantial Glucose-Lowering Effect, With Significant Differences Compared To Glipizide (A Sulfonylurea) In Weight Change and Hy
6/13/2006
-
Alexza Pharmaceuticals, Inc. To Present AZ-001 Phase IIa Clinical Data At The American Headache Society Meeting
6/13/2006
-
NeurogesX, Inc. Completes Enrollment In Pivotal Phase 3 Postherpetic Neuralgia Trial
6/13/2006
-
Speedel Pharmaceuticals, Inc. Release: New Data On Renin Inhibitor SPP100 (Rasilez) Demonstrates Its Potential Use In Diabetic Patients
6/13/2006
-
ChemGenex Pharmaceuticals Limited Launches Multinational Phase 2/3 Study For CML Patients With The T315I Mutation
6/13/2006
-
IDM Pharma, Inc. Receives Special Protocol Assessment From FDA For Phase 2/3 Trial Of Bexidem For Superficial Bladder Cancer
6/13/2006
-
Alexion Pharmaceuticals Inc. Reports Positive Interim Safety And Efficacy Results For Soliris(TM) (eculizumab) From The Open-Label Phase III SHEPHERD Safety Trial In Paroxysmal Nocturnal Hemoglobinuria Patients
6/12/2006
-
Pfizer Inc. Release: New Exubera Data To Be Presented At American Diabetes Association Meeting
6/12/2006
-
Newly Released Phase III Studies For JANUVIA(TM), Merck & Co., Inc.'s Investigational Once-Daily Medicine For Type 2 Diabetes, Showed Significantly Reduced Blood Sugar Levels When Used As Monotherapy Or As Add-On Treatment
6/12/2006
-
Eli Lilly and Company And Alkermes Release: Data On AIR(R) Inhaled Insulin System Presented At American Diabetes Association Meeting
6/12/2006
-
Eli Lilly and Company Release: Investigational Treatment Ruboxistaurin Demonstrated Promise In Reducing The Occurrence Of Vision Loss Caused By Diabetic Retinopathy
6/12/2006
-
Metabolex, Inc. Initiates Phase 2/3 Trial Of Metaglidasen In Patients With Type 2 Diabetes
6/12/2006
-
MediciNova, Inc. Announces Results From A Phase II/III Generalized Anxiety Disorder Trial With MN-305
6/12/2006
-
Nektar Therapeutics Reports Pfizer Inc. Announcement Of New Exubera Data
6/12/2006
-
Merck & Co., Inc. Conference Call And Audio Web Cast To Discuss Phase III Efficacy And Safety Data On JANUVIA
6/9/2006
-
Spectrum Pharmaceuticals, Inc. Release: Independent Data Monitoring Board Recommends That Satraplatin Phase 3 Trial Continue As Planned
6/8/2006
-
NeoPharm Announces PRECISE Trial Has Reached Criteria For Interim Efficacy Analysis
6/8/2006
-
YM BioSciences Says Monitor Has Questions On Study
6/7/2006